176 related articles for article (PubMed ID: 29150210)
1. A behavioral economics approach to the failed HPV vaccination program in Japan.
Yagi A; Ueda Y; Kimura T
Vaccine; 2017 Dec; 35(50):6931-6933. PubMed ID: 29150210
[No Abstract] [Full Text] [Related]
2. HPV vaccination in Japan: what is happening in Japan?
Ikeda S; Ueda Y; Yagi A; Matsuzaki S; Kobayashi E; Kimura T; Miyagi E; Sekine M; Enomoto T; Kudoh K
Expert Rev Vaccines; 2019 Apr; 18(4):323-325. PubMed ID: 30768373
[No Abstract] [Full Text] [Related]
3. [HPV Vaccination Program - The History and Recent Progress].
Yoshikawa H
Gan To Kagaku Ryoho; 2017 Sep; 44(9):713-716. PubMed ID: 28912394
[TBL] [Abstract][Full Text] [Related]
4. Compensation programs after withdrawal of the recommendation for HPV vaccine in Japan.
Yuji K; Nakada H
Hum Vaccin Immunother; 2016 May; 12(5):1321-4. PubMed ID: 26513303
[TBL] [Abstract][Full Text] [Related]
5. Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccination.
Morimoto A; Ueda Y; Egawa-Takata T; Yagi A; Terai Y; Ohmichi M; Ichimura T; Sumi T; Murata H; Kanzaki H; Nakai H; Mandai M; Yoshino K; Fujita M; Kimura T; Saito J; Sobue T; Nishikawa N; Sekine M; Enomoto T; Horikoshi Y; Takagi T
Int J Clin Oncol; 2015 Jun; 20(3):549-55. PubMed ID: 25001869
[TBL] [Abstract][Full Text] [Related]
6. Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation.
Larson HJ; Wilson R; Hanley S; Parys A; Paterson P
Hum Vaccin Immunother; 2014; 10(9):2543-50. PubMed ID: 25483472
[TBL] [Abstract][Full Text] [Related]
7. Background paper for the recommendation of HPV vaccination for boys in Germany.
Takla A; Wiese-Posselt M; Harder T; Meerpohl JJ; Röbl-Mathieu M; Terhardt M; van der Sande M; Wichmann O; Zepp F; Klug SJ
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Sep; 61(9):1170-1186. PubMed ID: 30167729
[No Abstract] [Full Text] [Related]
8. Struggles within Japan's national HPV vaccination: A proposal for future strategy.
Tanaka Y; Ueda Y; Kimura T
Hum Vaccin Immunother; 2017 May; 13(5):1167-1168. PubMed ID: 28059676
[No Abstract] [Full Text] [Related]
9. Safety of HPV vaccines in the age of nonavalent vaccination.
Quattrone F; Canale A; Filippetti E; Tulipani A; Porretta A; Lopalco PL
Minerva Pediatr; 2018 Feb; 70(1):59-66. PubMed ID: 29363293
[TBL] [Abstract][Full Text] [Related]
10. Promoting the immunization neighborhood: Benefits and challenges of pharmacies as additional locations for HPV vaccination.
Rothholz M; Tan LLJ
Hum Vaccin Immunother; 2017 Aug; 13(8):1856-1858. PubMed ID: 27216035
[No Abstract] [Full Text] [Related]
11. Time-dependent changes of the intention of mothers in Japan to inoculate their daughters with the HPV vaccine after suspension of governmental recommendation.
Yagi A; Ueda Y; Tanaka Y; Nakae R; Kakubari R; Morimoto A; Terai Y; Ohmichi M; Ichimura T; Sumi T; Murata H; Okada H; Nakai H; Matsumura N; Yoshino K; Kimura T; Saito J; Ikeda S; Asai-Sato M; Miyagi E; Sekine M; Enomoto T; Hirai K; Horikoshi Y; Takagi T; Shimura K
Hum Vaccin Immunother; 2018; 14(10):2497-2502. PubMed ID: 29883254
[TBL] [Abstract][Full Text] [Related]
12. Engaging parents and schools improves uptake of the human papillomavirus (HPV) vaccine: examining the role of the public health nurse.
Whelan NW; Steenbeek A; Martin-Misener R; Scott J; Smith B; D'Angelo-Scott H
Vaccine; 2014 Aug; 32(36):4665-71. PubMed ID: 24992714
[TBL] [Abstract][Full Text] [Related]
13. Including males in Canadian human papillomavirus vaccination programs: a policy analysis.
Shapiro GK; Perez S; Rosberger Z
CMAJ; 2016 Sep; 188(12):881-886. PubMed ID: 27114488
[No Abstract] [Full Text] [Related]
14. The controversy on HPV vaccination in Japan: Criticism of the ethical validity of the arguments for the suspension of the proactive recommendation.
Okita T; Enzo A; Kadooka Y; Tanaka M; Asai A
Health Policy; 2020 Feb; 124(2):199-204. PubMed ID: 31924344
[TBL] [Abstract][Full Text] [Related]
15. A retrospective and prospective look at strategies to increase adolescent HPV vaccine uptake in the United States.
Head KJ; Biederman E; Sturm LA; Zimet GD
Hum Vaccin Immunother; 2018 Jul; 14(7):1626-1635. PubMed ID: 29359986
[TBL] [Abstract][Full Text] [Related]
16. High HPV vaccination uptake rates for adolescent girls after regional governmental funding in Shiki City, Japan.
Hayashi Y; Shimizu Y; Netsu S; Hanley S; Konno R
Vaccine; 2012 Aug; 30(37):5547-50. PubMed ID: 22749837
[TBL] [Abstract][Full Text] [Related]
17. Early impact of the Japanese immunization program implemented before the HPV vaccination crisis.
Matsumoto K; Yaegashi N; Iwata T; Yamamoto K; Nagashima M; Saito T; Ushijima K; Takahashi F; Noda K; Yoshikawa H
Int J Cancer; 2017 Oct; 141(8):1704-1706. PubMed ID: 28657110
[No Abstract] [Full Text] [Related]
18. Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan.
Nakagawa S; Ueda Y; Yagi A; Ikeda S; Hiramatsu K; Kimura T
Cancer Sci; 2020 Jun; 111(6):2156-2162. PubMed ID: 32248632
[TBL] [Abstract][Full Text] [Related]
19. Population-wide vaccination against human papillomavirus in adolescent boys: Australia as a case study.
Georgousakis M; Jayasinghe S; Brotherton J; Gilroy N; Chiu C; Macartney K
Lancet Infect Dis; 2012 Aug; 12(8):627-34. PubMed ID: 22445354
[TBL] [Abstract][Full Text] [Related]
20. Relationship between maternal experiences and adolescent HPV vaccination.
Berenson AB; Brown VG; Fuchs EL; Hirth JM; Chang M
Hum Vaccin Immunother; 2017 Sep; 13(9):2150-2154. PubMed ID: 28604258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
